Recent Publications
Prior to the enactment of the Compassionate Care Act, a vast number of practitioners relied on prescription opioids to treat patients with severe pain. Now, a practitioner may certify patients to use an approved medical marijuana product (as an alternative to opioids as part of a patient’s treatment plan), under the New York State Medical Marijuana Program (“MMP”) and current emergency regulations.
As per applicable New York State law, certain providers in New York State are required to have an effective compliance program in place and certify on an annual basis that such compliance plan has been implemented and is effective.
It is tough being a provider today. Providers are expected to provide top quality clinical care to their patients and comply with the myriad of rules and regulations governing health care providers at the federal and state level, in additional to rules and regulations instituted by third party payors. Failure to comply can result in serious repercussions, including an audit and subsequent overpayment demand in connection with services previously rendered and paid for, criminal action, financial penalties and potential loss of license.
READ MORE